Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Nhu CoSZSE:002001 -1.38%98 Pretax Margin % is 37.48% as of Jun. 2026, which is 11% above its 10-year median of 33.72. GuruFocus rates SZSE:002001 with a GF Score™ of 98/100 and a GF Value™ of ¥28.59 (Fairly Valued). The stock has 3 warning signs investors should review. Among 960 Drug Manufacturers companies, Zhejiang Nhu Co ranks better than 93.85% on this metric.
The historical rank and industry rank for Zhejiang Nhu Co's Pretax Margin % or its related term are showing as below:
SZSE:002001'
s Pretax Margin % Range Over the Past 10 Years
Min: 21.52 Med: 33.72 Max: 41.92
Current: 34.26
SZSE:002001's Pretax Margin % is ranked better than 93.85% of 960
companies
in the Drug Manufacturers industry
Industry Median: 7.155
vs SZSE:002001: 34.26
Zhejiang Nhu Co (SZSE:002001) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Zhejiang Nhu Co Pretax Margin % Related Terms
Zhejiang Nhu Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Zhejiang Nhu Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Nhu Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Nhu Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Nhu Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Zhejiang Nhu Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Nhu Co (SZSE:002001) has a Pretax Margin % of 37.48% as of Jun. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Zhejiang Nhu Co and its competitors. This is 11% above median its historical median of 33.72. Over the past decade, Zhejiang Nhu Co's Pretax Margin % has ranged from 21.52 to 41.92. According to the industry distribution chart, Zhejiang Nhu Co ranks #59 out of 960 companies in the Drug Manufacturers industry, placing it in the top 6.1%.
Is Zhejiang Nhu Co's Pretax Margin % too high?
Zhejiang Nhu Co's current Pretax Margin % of 37.48% is 11% above median its 10-year median of 33.72. Over the past 10 years, this metric has ranged from a low of 21.52 to a high of 41.92. The Drug Manufacturers industry median Pretax Margin % is 7.16. Zhejiang Nhu Co's value of 37.48% is 423.8% above this industry median. Based on the distribution chart, Zhejiang Nhu Co ranks #59 out of 960 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Nhu Co has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Nhu Co's Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Nhu Co ranks #59 out of 960 companies for Pretax Margin %. This places Zhejiang Nhu Co in the top 6% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.16. Zhejiang Nhu Co's value of 37.48% is 423.8% above this benchmark. Historically, Zhejiang Nhu Co's own Pretax Margin % has ranged from 21.52 to 41.92 over the past decade. While the company's 10-year median is 33.72 vs. the industry median of 7.16, Zhejiang Nhu Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.16, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Nhu Co's current Pretax Margin % of 37.48% is 423.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Zhejiang Nhu Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Nhu Co's current Pretax Margin % is 37.48%, which is 11% above median its own 10-year median of 33.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Nhu Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Nhu Co (SZSE:002001) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.59, compared to a current price of ¥26.49 — trading 7.3% below its estimated fair value. The current Pretax Margin % is 37.48%, which is 11% above median its 10-year median of 33.72 and 423.8% above the Drug Manufacturers industry median of 7.16. Zhejiang Nhu Co's overall GF Score™ is 98/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Zhejiang Nhu Co (SZSE:002001), the current Pretax Margin % is 37.48% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Nhu Co (SZSE:002001) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Nhu Co stock appears to be undervalued.
The current stock price of ¥26.49 is trading 7.3% below its estimated GF Value™ of ¥28.59.
GuruFocus considers Zhejiang Nhu Co to be Fairly Valued.
Key valuation signals for SZSE:002001:
Pretax Margin %: 37.48% (11% above median its 10-year median of 33.72)
GF Value™: ¥28.59 vs. price of ¥26.49 (7.3% below fair value)
Industry Position: 423.8% above the Drug Manufacturers median (#59 of 960)
No single metric tells the full story. See the SZSE:002001 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives, and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer, and Anti-bacterial, with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3, and coenzyme Q10, and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.
98GF Score
Get the complete analysis for SZSE:002001
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002001 has been successfully added to your 
